DNMT3A and acute myeloid leukemia: Epigenetic mutations of DNMT3A, TET2, and ASXL1 have been identified in preleukaemic haemopoietic stem cells decades before the development of AML, suggesting that these are early founder events that precede leukemogenic transformation [25].